Isotretinoin-induced myositis.


Journal

Oxford medical case reports
ISSN: 2053-8855
Titre abrégé: Oxf Med Case Reports
Pays: England
ID NLM: 101642070

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 04 11 2023
revised: 05 02 2024
accepted: 09 02 2024
medline: 27 3 2024
pubmed: 27 3 2024
entrez: 27 3 2024
Statut: epublish

Résumé

Retinoid-induced myositis is a phenomenon recognised in multiple case reports. We report a case of isotretinoin-induced myositis in an 18-year-old male patient. This case adds to the published literature as it demonstrates (i) myositis may occur after extended periods of isotretinoin use, (ii) should be considered as a differential diagnosis even when presenting asymmetrically and (iii) can continue to progress clinically and biochemically initially following the suspension of isotretinoin before being effectively treated with corticosteroids.

Identifiants

pubmed: 38532764
doi: 10.1093/omcr/omae017
pii: omae017
pmc: PMC10962232
doi:

Types de publication

Case Reports

Langues

eng

Pagination

omae017

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press.

Déclaration de conflit d'intérêts

None.

Auteurs

Oliver Hague (O)

Department of Rheumatology, Royal Free Hospital, London NW3 2QG, United Kingdom.

Vasiliki Thanopoulou (V)

Department of Rheumatology, Royal Free Hospital, London NW3 2QG, United Kingdom.

Pamela Mangat (P)

Department of Rheumatology, Royal Free Hospital, London NW3 2QG, United Kingdom.

Animesh Singh (A)

Department of Rheumatology, Royal Free Hospital, London NW3 2QG, United Kingdom.

Richard Stratton (R)

Department of Rheumatology, Royal Free Hospital, London NW3 2QG, United Kingdom.

Tamir Malley (T)

Department of Rheumatology, Royal Free Hospital, London NW3 2QG, United Kingdom.

Classifications MeSH